{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T14:01:36Z","timestamp":1788012096239,"version":"build-2784847793"},"reference-count":74,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T00:00:00Z","timestamp":1452211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0146480","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T13:35:59Z","timestamp":1452260159000},"page":"e0146480","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":56,"title":["A Metabolic Study of Huntington\u2019s Disease"],"prefix":"10.1371","volume":"11","author":[{"given":"Rajasree","family":"Nambron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edina","family":"Silajd\u017ei\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Kalliolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Ottolenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hindmarsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan R.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se\u00e1n J.","family":"Costelloe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas G.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Positano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary C.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bj\u00f6rkqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas T.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,1,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"c3109","DOI":"10.1136\/bmj.c3109","article-title":"Huntington&apos;s disease","volume":"340","author":"MJ Novak","year":"2010","journal-title":"BMJ"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington&apos;s disease","volume":"8","author":"JM van der Burg","year":"2009","journal-title":"Lancet Neurol"},{"issue":"3\u20134","key":"ref3","first-page":"223","article-title":"Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington&apos;s disease: clinical consequences and therapeutic implications","volume":"18","author":"NA Aziz","year":"2007","journal-title":"Rev Neurosci"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1460-9568.2006.04985.x","article-title":"Hypothalamic-endocrine aspects in Huntington&apos;s disease","volume":"24","author":"A Petersen","year":"2006","journal-title":"Eur J Neurosci"},{"issue":"Pt 4","key":"ref5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/brain\/awl027","article-title":"Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles","volume":"129","author":"BR Underwood","year":"2006","journal-title":"Brain"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0004.1985.tb00185.x","article-title":"Diabetes mellitus in Huntington disease","volume":"27","author":"LA Farrer","year":"1985","journal-title":"Clin Genet"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000212174","article-title":"Abnormal glucose tolerance and arginine tolerance tests in Huntington&apos;s disease","volume":"23","author":"S Podolsky","year":"1977","journal-title":"Gerontology"},{"issue":"7765","key":"ref8","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(72)91092-6","article-title":"Increased frequency of diabetes mellitus in patients with Huntington&apos;s chorea","volume":"1","author":"S Podolsky","year":"1972","journal-title":"Lancet"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archneur.65.4.476","article-title":"Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion","volume":"65","author":"NM Lalic","year":"2008","journal-title":"Arch Neurol"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1365-2826.2009.01898.x","article-title":"Huntington&apos;s disease does not appear to increase the risk of diabetes mellitus","volume":"21","author":"TW Boesgaard","year":"2009","journal-title":"J Neuroendocrinol"},{"key":"ref11","first-page":"807","article-title":"Normal glucose, insulin, and growth hormone responses to oral glucose in Huntington&apos;s disease","volume":"84","author":"MB Davidson","year":"1974","journal-title":"Journal of Laboratory and Clinical Medicine"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jnnp.39.3.244","article-title":"Altered growth hormone release in Huntington&apos;s chorea","volume":"39","author":"HJ Keogh","year":"1976","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0022-510X(89)90120-2","article-title":"Endocrine functions in Huntington&apos;s disease. A two-and-a-half years follow-up study","volume":"90","author":"HP Kremer","year":"1989","journal-title":"J Neurol Sci"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1371\/journal.pone.0000647","article-title":"Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression","volume":"2","author":"F Mochel","year":"2007","journal-title":"PLoS One"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nut.2003.10.007","article-title":"Assessment of the nutrition status of patients with Huntington&apos;s disease","volume":"20","author":"A Trejo","year":"2004","journal-title":"Nutrition"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ajpa.1330670304","article-title":"An anthropometric assessment of Huntington&apos;s disease patients and families","volume":"67","author":"LA Farrer","year":"1985","journal-title":"Am J Phys Anthropol"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ajmg.1320210213","article-title":"Anthropometric discrimination among affected, at-risk, and not-at-risk individuals in families with Huntington disease","volume":"21","author":"LA Farrer","year":"1985","journal-title":"Am J Med Genet"},{"issue":"3","key":"ref18","first-page":"311","article-title":"Plasma glucose, non-esterified fatty acids and amino acids in Huntington&apos;s chorea","volume":"52","author":"OT Phillipson","year":"1977","journal-title":"Clin Sci Mol Med"},{"issue":"17","key":"ref19","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/11.17.1953","article-title":"Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses","volume":"11","author":"S Sipione","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"43","key":"ref20","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","article-title":"Dysfunction of the cholesterol biosynthetic pathway in Huntington&apos;s disease","volume":"25","author":"M Valenza","year":"2005","journal-title":"J Neurosci"},{"issue":"Pt 11","key":"ref21","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/brain\/awn212","article-title":"Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington&apos;s disease","volume":"131","author":"V Leoni","year":"2008","journal-title":"Brain"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neulet.2011.03.025","article-title":"Whole body cholesterol metabolism is impaired in Huntington&apos;s disease","volume":"494","author":"V Leoni","year":"2011","journal-title":"Neurosci Lett"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ymgme.2007.10.002","article-title":"Low plasma total cholesterol in patients with Huntington&apos;s disease and first-degree relatives","volume":"93","author":"M Markianos","year":"2008","journal-title":"Mol Genet Metab"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fphys.2014.00231","article-title":"Metabolic and hormonal signatures in pre-manifest and manifest Huntington&apos;s disease patients","volume":"5","author":"R Wang","year":"2014","journal-title":"Frontiers in physiology"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410410206","article-title":"Energy metabolism defects in Huntington&apos;s disease and effects of coenzyme Q10","volume":"41","author":"WJ Koroshetz","year":"1997","journal-title":"Ann Neurol"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I","article-title":"Abnormal in vivo skeletal muscle energy metabolism in Huntington&apos;s disease and dentatorubropallidoluysian atrophy","volume":"48","author":"R Lodi","year":"2000","journal-title":"Ann Neurol"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/mds.20373","article-title":"Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington&apos;s disease","volume":"20","author":"C Saft","year":"2005","journal-title":"Mov Disord"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/ejhg.2010.72","article-title":"Dietary anaplerotic therapy improves peripheral tissue energy metabolism in patients with Huntington&apos;s disease","volume":"18","author":"F Mochel","year":"2010","journal-title":"European journal of human genetics: EJHG"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0447.1971.tb02141.x","article-title":"Serum levels of phenylalanine and tyrosine in Huntington&apos;s chorea","volume":"221","author":"JO Ottosson","year":"1971","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"ref30","author":"JO Ottosson","year":"1973"},{"issue":"7599","key":"ref31","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0140-6736(69)92068-6","article-title":"Plasma-aminoacid levels in Huntington&apos;s chorea","volume":"1","author":"TL Perry","year":"1969","journal-title":"Lancet"},{"key":"ref32","author":"TL Perry","year":"1973"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-0404.1995.tb00438.x","article-title":"Decreased plasma alanine and isoleucine in Huntington&apos;s disease","volume":"91","author":"R Reilmann","year":"1995","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0009-8981(73)90169-1","article-title":"Lysosomal enzymes, amino acids and acid metabolites of amines in Huntington&apos;s chorea","volume":"44","author":"CM Yates","year":"1973","journal-title":"Clin Chim Acta"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1677\/joe.1.05866","article-title":"Appetite control","volume":"184","author":"K Wynne","year":"2005","journal-title":"J Endocrinol"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1467-789X.2006.00270.x","article-title":"The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review","volume":"8","author":"MD Klok","year":"2007","journal-title":"Obes Rev"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1196\/annals.1433.054","article-title":"Central nervous system regulation of energy metabolism: ghrelin versus leptin","volume":"1126","author":"R Nogueiras","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/1531-8249(200001)47:1<64::AID-ANA11>3.0.CO;2-S","article-title":"Higher sedentary energy expenditure in patients with Huntington&apos;s disease","volume":"47","author":"RE Pratley","year":"2000","journal-title":"Ann Neurol"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/ajcn\/81.6.1335","article-title":"Energy balance in early-stage Huntington disease","volume":"81","author":"AM Gaba","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/eje.0.1510451","article-title":"Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington&apos;s disease","volume":"151","author":"V Popovic","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/mds.26003","article-title":"Plasma melatonin is reduced in Huntington&apos;s disease","volume":"29","author":"E Kalliolia","year":"2014","journal-title":"Mov Disord"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington&apos;s Disease Rating Scale: reliability and consistency. Huntington Study Group","volume":"11","year":"1996","journal-title":"Mov Disord"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.29.1.1","article-title":"Huntington disease: clinical care and evaluation","volume":"29","author":"I Shoulson","year":"1979","journal-title":"Neurology"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/mds.870130609","article-title":"Unified Huntington&apos;s disease rating scale: a follow up","volume":"13","author":"S Siesling","year":"1998","journal-title":"Mov Disord"},{"key":"ref45","unstructured":"Huntington Study Group. Unified Huntington&apos;s Disease Rating Scale-99. Rochester, NY1999."},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/jmri.20167","article-title":"An accurate and robust method for unsupervised assessment of abdominal fat by MRI","volume":"20","author":"V Positano","year":"2004","journal-title":"J Magn Reson Imaging"},{"issue":"10","key":"ref47","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/hmg\/ddl094","article-title":"Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6\/2 transgenic mouse model of Huntington&apos;s disease","volume":"15","author":"M Bjorkqvist","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/hmg\/10.2.145","article-title":"Abnormalities in the functioning of adipocytes from R6\/2 mice that are transgenic for the Huntington&apos;s disease mutation","volume":"10","author":"JN Fain","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/hmg\/ddn428","article-title":"Adipose tissue dysfunction tracks disease progression in two Huntington&apos;s disease mouse models","volume":"18","author":"J Phan","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1468-1331.2009.02798.x","article-title":"Growth hormone and ghrelin secretion are associated with clinical severity in Huntington&apos;s disease","volume":"17","author":"NA Aziz","year":"2010","journal-title":"Eur J Neurol"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2265.2009.03661.x","article-title":"Leptin secretion rate increases with higher CAG repeat number in Huntington&apos;s disease patients","volume":"73","author":"NA Aziz","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"ref52","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.2337\/dc12-0607","article-title":"Expansion of the homeostasis model assessment of beta-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2","volume":"36","author":"NR Hill","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1177\/193229681300700308","article-title":"Methodology for quantifying fasting glucose homeostasis in type 2 diabetes: observed variability and lability","volume":"7","author":"NR Hill","year":"2013","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"WT Friedewald","year":"1972","journal-title":"Clinical chemistry"},{"issue":"7","key":"ref55","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrrheum.2012.86","article-title":"Bone turnover markers: use in osteoporosis","volume":"8","author":"K Naylor","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.ijo.0803409","article-title":"Validity of a new automated software program for visceral adipose tissue estimation","volume":"31","author":"EW Demerath","year":"2007","journal-title":"Int J Obes (Lond)"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/hmg\/ddi053","article-title":"The R6\/2 transgenic mouse model of Huntington&apos;s disease develops diabetes due to deficient beta-cell mass and exocytosis","volume":"14","author":"M Bjorkqvist","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"2","key":"ref58","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00221-005-2357-z","article-title":"Atypical diabetes associated with inclusion formation in the R6\/2 mouse model of Huntington&apos;s disease is not improved by treatment with hypoglycaemic agents","volume":"166","author":"MJ Hunt","year":"2005","journal-title":"Exp Brain Res"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/jcem-39-1-36","article-title":"Growth hormone abnormalities in Huntington&apos;s chorea: effect of L-dopa administration","volume":"39","author":"S Podolsky","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"ref60","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/jnnp.44.5.414","article-title":"Studies of hypothalamic function in Huntington&apos;s chorea","volume":"44","author":"PJ Lavin","year":"1981","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5717","key":"ref61","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1126\/science.1109951","article-title":"The gut and energy balance: visceral allies in the obesity wars","volume":"307","author":"MK Badman","year":"2005","journal-title":"Science"},{"issue":"2","key":"ref62","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0092-8674(03)01081-X","article-title":"Obesity wars: molecular progress confronts an expanding epidemic","volume":"116","author":"JS Flier","year":"2004","journal-title":"Cell"},{"issue":"2","key":"ref63","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.expneurol.2007.12.026","article-title":"The metabolic profile of early Huntington&apos;s disease\u2014a combined human and transgenic mouse study","volume":"210","author":"AO Goodman","year":"2008","journal-title":"Exp Neurol"},{"issue":"9","key":"ref64","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","article-title":"Weight loss in early stage of Huntington&apos;s disease","volume":"59","author":"L Djousse","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"ref65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pneurobio.2006.09.005","article-title":"Cholesterol dysfunction in neurodegenerative diseases: is Huntington&apos;s disease in the list?","volume":"80","author":"M Valenza","year":"2006","journal-title":"Progress in neurobiology"},{"issue":"1","key":"ref66","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jacl.2009.11.003","article-title":"Altered cholesterol and fatty acid metabolism in Huntington disease","volume":"4","author":"RC Block","year":"2010","journal-title":"J Clin Lipidol"},{"issue":"11","key":"ref67","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1111\/j.1460-9568.2004.03783.x","article-title":"Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington&apos;s disease mutation","volume":"20","author":"RR Ribchester","year":"2004","journal-title":"Eur J Neurosci"},{"issue":"3","key":"ref68","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","article-title":"Tryptophan metabolism and oxidative stress in patients with Huntington&apos;s disease","volume":"93","author":"N Stoy","year":"2005","journal-title":"J Neurochem"},{"issue":"4","key":"ref69","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.ATV.0000012303.37971.DA","article-title":"RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function","volume":"22","author":"M Schoppet","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"ref70","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/rheumatology\/ken385","article-title":"Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis","volume":"47","author":"ST Choi","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"ref71","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrrheum.2012.157","article-title":"The skeleton as an endocrine organ","volume":"8","author":"DJ DiGirolamo","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"ref72","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jbmr.321","article-title":"The osteoblast: an insulin target cell controlling glucose homeostasis","volume":"26","author":"TL Clemens","year":"2011","journal-title":"J Bone Miner Res"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"RRN1214","DOI":"10.1371\/currents.RRN1214","article-title":"Body composition in premanifest Huntington&apos;s disease reveals lower bone density compared to controls","volume":"3","author":"AO Goodman","year":"2011","journal-title":"PLoS Curr"},{"issue":"1","key":"ref74","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/JHD-130049","article-title":"A critical evaluation of inflammatory markers in Huntington&apos;s Disease plasma","volume":"2","author":"E Silajdzic","year":"2013","journal-title":"J Huntingtons Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0146480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T15:19:43Z","timestamp":1600010383000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0146480"}},"subtitle":[],"editor":[{"given":"Juergen","family":"Eckel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,1,8]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0146480","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,8]]}}}